Quture International, Inc. Announces Postponement of Scheduled

Quture International, Inc. Announces Postponement of Scheduled
Shareholder Conference Call 
DAYTONA BEACH, FL -- (Marketwire) -- 01/22/13 --  Quture
International, Inc. (OTCQB: QUTR) announced today that they are
postponing the previously scheduled shareholder conference call on
Wednesday, January 23, 2013, at 4:15 p.m. Eastern Standard Time. The
press of business and completion of pending accomplishments requires
the full time and attention of Quture's Chairman and CEO, Landon
Feazell, who was to host the call.  
Quture plans to host quarterly shareholder calls in 2013 scheduled
around reportable accomplishments and to make announcements. A series
of press releases have chronicled the Company's progress and growth,
which the Company expects to promote as it continues to be optimistic
about its product and market position. As Quture continues its growth
and transition from development of its QualOptima product to
marketing and sales, the Company is strategically positioning for
success in the healthcare performance and outcomes analytics market.
Quture is actively engaged in potential agreements for national and
international sales contracts as a Breakthrough Application partner
with InterSystems Corporation. Quture is further committed to
changing the pedigree of the Company with announced and unannounced
additions to the Management Team and key independent contractors. As
these transitions mature, the Company has a commitment to our
shareholders as well as the investment community for maximum
disclosure and communication. 
International, Inc. (QUTR) is the proven and experienced performance
and outcomes analytics company in the United States. The vision of
Quture is to connect all constituents in the global health and health
care community to clinically and financially focused and sound data
transformed through analytics to knowledge that empowers data-driven
decisions for results-driven success. As a "Breakthrough" Application
Partner of InterSystems Corporation, Quture's technology for
capturing, integrating and aggregating data on the InterSystems
Enterprise platform is unequalled. The Company's unique product
QualOptima develops a second generation CLINICAL database
implementing Qutur
e's core competence of clinical content with
evidence-based metrics developed for more than 35 years. QualOptima
empowers clinical performance enhancement to achieve optimal patient
outcomes. Quture's brand is centered on the value proposition of
trust, transparency and independence. As the free enterprise solution
to improving health and healthcare while reducing costs, Quture is
positioned to become the leading clinical knowledge company in the
world. Quture International is a Nevada corporation trading under the
symbol QUTR. 
This release contains forward-looking statements, including, without
limitation, statements concerning our business and possible or
assumed future results of operations. Our actual results could differ
materially from those anticipated in the forward-looking statements
for many reasons including: our ability to continue as a going
concern, adverse economic changes affecting markets we serve;
competition in our markets and industry segments; our timing and the
profitability of entering new markets; greater than expected costs,
customer acceptance of our products or difficulties related to our
integration of the businesses we may acquire; and other risks and
uncertainties as may be detailed from time to time in our public
announcements and SEC filings. Although we believe the expectations
reflected in the forward-looking statements are reasonable, they
relate only to events as of the date on which the statements are
made, and our future results, levels of activity, performance or
achievements may not meet these expectations. We do not intend to
update any of the forward-looking statements after the date of this
document to conform these statements to actual results or to changes
in our expectations, except as required by law. There is no assurance
that a definitive agreement will be completed.  
For Further Information Contact:
Constellation Asset Advisors, Inc.
Jens Dalsgaard
+1 (415) 524-8500 
Mele Telitz
Director of Communications
(855) 740-7878 (QUTR)
Press spacebar to pause and continue. Press esc to stop.